Znanstveni rad - Izvorni znanstveni rad
Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate
Cancer, 125 (2019), 13; 2222-2232. https://doi.org/10.1002/cncr.32033

Mrđenović, Stefan; Zhang, Yi; Wang, Ruoxiang; Yin, Lijuan; Chia-Yi Chu, Gina; Yin, Liyuan; Lewis, Michael; Heffer, Marija; Zhau, Haiyen E.; Chung, Leland W. K.

Citirajte ovaj rad

Mrđenović, S., Zhang, Y., Wang, R., Yin, L., Chia Yi Chu, G., Yin, L. ... Chung, L. W. K. (2019). Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate. Cancer, 125. (13), 2222-2232. doi: 10.1002/cncr.32033

Mrđenović, Stefan, et al. "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate." Cancer, vol. 125, br. 13, 2019, str. 2222-2232. https://doi.org/10.1002/cncr.32033

Mrđenović, Stefan, Yi Zhang, Ruoxiang Wang, Lijuan Yin, Gina Chia Yi Chu, Liyuan Yin, Michael Lewis, Marija Heffer, Haiyen E. Zhau i Leland W. K. Chung. "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate." Cancer 125, br. 13 (2019): 2222-2232. https://doi.org/10.1002/cncr.32033

Mrđenović, S., et al. (2019) 'Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate', Cancer, 125(13), str. 2222-2232. doi: 10.1002/cncr.32033

Mrđenović S, Zhang Y, Wang R, Yin L, Chia Yi Chu G, Yin L, i sur.. Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate. Cancer [Internet]. 2019. [pristupljeno 29.11.2020.];125(13):2222-2232. doi: 10.1002/cncr.32033

S. Mrđenović, et al., "Targeting Burkitt Lymphoma with a Tumor Cell–specific Heptamethine Carbocyanine-cisplatin Conjugate", Cancer, vol. 125, br. 13, str. 2222-2232, 2019. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:239:300171. [Citirano: 29.11.2020.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.